GeneDx Holdings Corp. WGS 55.99 GeneDx Holdings Corp.

Home
⇒ 
Stock List ⇒ GeneDx Holdings Corp.
Range:1.16-60.8Vol Avg:467989Last Div:0Changes:5
Beta:2.38Cap:1.62BCurrency:USDExchange:NASDAQ
Sector:HealthcareIPO:Wed Nov 04 2020Empoloyees:1000
CUSIP:81663L200CIK:0001818331ISIN:US81663L2007Country:US
CEO:Ms. Katherine A. StuelandWebsite:https://www.genedx.com
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow